Molecular Medicine |
From the Second Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan.
Correspondence to Ryozo Nagai, MD, Second Department of Internal Medicine, Gunma University School of Medicine, 3-39-15, Showa-machi, Maebashi, Gunma, 371-8511, Japan.
AbstractWe have recently demonstrated that a developmentally regulated zinc finger protein, basic transcription regulatory element binding protein 2 (BTEB2), is induced in neointimal smooth muscle in response to vascular injury. In this study, we investigated the molecular mechanisms regulating BTEB2 expression in vascular smooth muscle cells (SMCs) in vitro. BTEB2 mRNA expression is rapidly and persistently induced in SMCs by phorbol 12-myristate 13-acetate (PMA) and basic fibroblast growth factor. We have isolated and characterized the promoter region of the human BTEB2 gene to determine the regulatory network controlling expression of this gene in vascular SMCs. Functional studies on the BTEB2 promoter coupled to a luciferase reporter gene demonstrated activation of the promoter by PMA and basic fibroblast growth factor. Both characterization of DNA-protein complexes in vitro and site-specific mutation analysis of the BTEB2 promoter have defined a 9-bp sequence, 5'-CGCCCGCGC-3', located at -25, as the Egr-1 binding site mediating an induction of the BTEB2 promoter activity by PMA. In addition, we show that this site mediates inducible expression through the mitogen-activated protein kinase pathways. These results indicate that BTEB2 is a target of the early-response gene Egr-1, and mitogen-activated protein kinase pathways directly or indirectly activate BTEB2 expression. Given a rapid induction of Egr-1 on stimulation with growth factors or injury, these findings may represent at least one of the molecular mechanisms underlying phenotypic modulation of smooth muscles after vascular injury.
Key Words: BTEB2 Egr-1 mitogen-activated protein kinase smooth muscle cell phenotypic modulation
This article has been cited by other articles:
![]() |
A. B. Bialkowska, Y. Du, H. Fu, and V. W. Yang Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening Mol. Cancer Ther., March 1, 2009; 8(3): 563 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wan, F. Luo, S. E. Wert, L. Zhang, Y. Xu, M. Ikegami, Y. Maeda, S. M. Bell, and J. A. Whitsett Kruppel-like factor 5 is required for perinatal lung morphogenesis and function Development, August 1, 2008; 135(15): 2563 - 2572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fisch, S. Gray, S. Heymans, S. M. Haldar, B. Wang, O. Pfister, L. Cui, A. Kumar, Z. Lin, S. Sen-Banerjee, et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy PNAS, April 24, 2007; 104(17): 7074 - 7079. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Du, C. C. Yun, A. Bialkowska, and V. W. Yang Protein Inhibitor of Activated STAT1 Interacts with and Up-regulates Activities of the Pro-proliferative Transcription Factor Kruppel-like Factor 5 J. Biol. Chem., February 16, 2007; 282(7): 4782 - 4793. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawai-Kowase and G. K. Owens Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells Am J Physiol Cell Physiol, January 1, 2007; 292(1): C59 - C69. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Baudino, W. Carver, W. Giles, and T. K. Borg Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1015 - H1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. Szabolcs, J. D. Terwilliger, and A. Efstratiadis Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene Carcinogenesis, May 1, 2006; 27(5): 1054 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chanchevalap, M. O. Nandan, B. B. McConnell, L. Charrier, D. Merlin, J. P. Katz, and V. W. Yang Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells Nucleic Acids Res., February 25, 2006; 34(4): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, X. Sun, P. Guo, X.-Y. Dong, P. Sethi, X. Cheng, J. Zhou, J. Ling, J. W. Simons, J. B. Lingrel, et al. Human Kruppel-like Factor 5 Is a Target of the E3 Ubiquitin Ligase WWP1 for Proteolysis in Epithelial Cells J. Biol. Chem., December 16, 2005; 280(50): 41553 - 41561. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pislaru and R. D. Simari The Translation of Transcription Circ. Res., November 25, 2005; 97(11): 1083 - 1084. [Full Text] [PDF] |
||||
![]() |
Y. Oyama, K. Kawai-Kowase, K. Sekiguchi, M. Sato, H. Sato, M. Yamazaki, Y. Ohyama, Y. Aihara, T. Iso, E. Okamaoto, et al. Homeobox Protein Hex Facilitates Serum Responsive Factor-Mediated Activation of the SM22{alpha} Gene Transcription in Embryonic Fibroblasts Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1602 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Usui, N. Sugimoto, N. Takuwa, S. Sakagami, S. Takata, S. Kaneko, and Y. Takuwa Blood Lipid Mediator Sphingosine 1-Phosphate Potently Stimulates Platelet-derived Growth Factor-A and -B Chain Expression through S1P1-Gi-Ras-MAPK-dependent Induction of Kruppel-like Factor 5 J. Biol. Chem., March 26, 2004; 279(13): 12300 - 12311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Day, G. Thiel, J. Lum, R. D. Chevere, Y. Yang, J. Stevens, L. Sibert, and B. L. Fanburg Hepatocyte Growth Factor Regulates Angiotensin Converting Enzyme Expression J. Biol. Chem., March 5, 2004; 279(10): 8792 - 8801. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aizawa, T. Suzuki, N. Kada, A. Ishihara, K. Kawai-Kowase, T. Matsumura, K. Sasaki, Y. Munemasa, I. Manabe, M. Kurabayashi, et al. Regulation of Platelet-derived Growth Factor-A Chain by Kruppel-like Factor 5: NEW PATHWAY OF COOPERATIVE ACTIVATION WITH NUCLEAR FACTOR-{kappa}B J. Biol. Chem., January 2, 2004; 279(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyamoto, T. Suzuki, S. Muto, K. Aizawa, A. Kimura, Y. Mizuno, T. Nagino, Y. Imai, N. Adachi, M. Horikoshi, et al. Positive and Negative Regulation of the Cardiovascular Transcription Factor KLF5 by p300 and the Oncogenic Regulator SET through Interaction and Acetylation on the DNA-Binding Domain Mol. Cell. Biol., December 1, 2003; 23(23): 8528 - 8541. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Manabe, T. Shindo, and R. Nagai Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Circ. Res., December 13, 2002; 91(12): 1103 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eyries, M. Agrapart, A. Alonso, and F. Soubrier Phorbol Ester Induction of Angiotensin-Converting Enzyme Transcription Is Mediated by Egr-1 and AP-1 in Human Endothelial Cells via ERK1/2 Pathway Circ. Res., November 15, 2002; 91(10): 899 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oyama, N. Akuzawa, R. Nagai, and M. Kurabayashi PPAR{gamma} Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells Circ. Res., February 22, 2002; 90(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sekiguchi, M. Kurabayashi, Y. Oyama, Y. Aihara, T. Tanaka, H. Sakamoto, Y. Hoshino, T. Kanda, T. Yokoyama, Y. Shimomura, et al. Homeobox Protein Hex Induces SMemb/Nonmuscle Myosin Heavy Chain-B Gene Expression Through the cAMP-Responsive Element Circ. Res., January 19, 2001; 88(1): 52 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Ziemer, D. Pennica, and A. J. Levine Identification of a Mouse Homolog of the Human BTEB2 Transcription Factor as a {beta}-Catenin-Independent Wnt-1-Responsive Gene Mol. Cell. Biol., January 15, 2001; 21(2): 562 - 574. [Abstract] [Full Text] |
||||
![]() |
N. G. Frangogiannis, L. H. Michael, and M. L. Entman Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb) Cardiovasc Res, October 1, 2000; 48(1): 89 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogata, M. Kurabayashi, Y.-i. Hoshino, K.-i. Sekiguchi, S. Ishikawa, Y. Morishita, and R. Nagai Inducible expression of basic transcription element-binding protein 2 in proliferating smooth muscle cells at the vascular anastomotic stricture J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 983 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sun, X. Chen, and V. W. Yang Intestinal-enriched Kruppel-like Factor (Kruppel-like Factor 5) Is a Positive Regulator of Cellular Proliferation J. Biol. Chem., March 2, 2001; 276(10): 6897 - 6900. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bieker Kruppel-like Factors: Three Fingers in Many Pies J. Biol. Chem., September 7, 2001; 276(37): 34355 - 34358. [Full Text] [PDF] |
||||
![]() |
Y. Oyama, N. Akuzawa, R. Nagai, and M. Kurabayashi PPAR{gamma} Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells Circ. Res., February 22, 2002; 90(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |